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This bachelor’s thesis presents a literature-based review of implantable pressure 
sensors. The focus is on the basic structure of implantable pressure sensors, and 
on two applications: intracranial pressure (ICP) and cardiovascular pressure 
(CVP). Implantable pressure sensor is a pressure sensor that is placed com-
pletely or partially inside the patient’s body. The basic structure of implantable 
pressure sensor includes the sensing element that measures the pressure, and 
a way of transmitting the measured values to a monitor for doctors to analyze. 
This can be done either with wires or wirelessly. In wireless sensors the data 
transmitting is often done either with radio frequencies or with an inductive link.  
 
Intracranial pressure is especially important to monitor after a traumatic brain in-
jury. Monitoring with implantable pressure sensors allows more accurate and con-
tinuous data, which is important, because it allows doctors to react faster in case 
the pressure values inside the brain would start to increase. With cardiovascular 
pressure monitoring, the implantable pressure sensors are used, for example, to 
monitor heart functioning after placing a ventricular assist device.  
 
Finally, the thesis discusses biodegradable implantable pressure sensors, which 
will be used in the future. At this point in time the biodegradable pressure sensors 
are undergoing in vitro and animal testing. Many of the test results are promising. 
The implantable biodegradable pressure sensors will decrease the risk of infec-
tions because they do not require surgery to be removed. Non-degradable pres-
sure sensors, however, do need removal surgery and more surgeries means 
more risk for infection.  
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Tämä kandidaatintutkielma on kirjallisuustutkimus implantoitavista paineantu-
reista. Tutkielmassa keskitytään implantoitavien paineantureiden perusrakentee-
seen ja kahteen yleiseen sovellukseen: kallonsisäisen paineen ja kardiovasku-
laarisen paineen mittaamiseen. Implantoitava paineanturi asetetaan osittain tai 
kokonaan kehon sisälle. Paineanturi rakentuu painetta mittaavasta elementistä, 
sekä joko johdoista tai langattomasta toteutuksesta, jolla mitatut painearvot saa-
daan kuljetettua monitorille, lääkäreille analysoitaviksi. Langattomassa toteutuk-
sessa painearvot yleensä lähetetään monitorille joko radioaalloilla tai induktiivi-
sen linkin avulla.  
 
Kallonsisäisen paineen mittaaminen on erityisen tärkeää vakavan päähän koh-
distuneen vamman jälkeen. Implantoitavilla paineantureilla saadaan tarkempia ja 
jatkuvia mittaustuloksia, mitkä ovat tärkeitä ominaisuuksia, sillä lääkäreiden on 
pystyttävä reagoimaan nopeasti mikäli painearvot alkavat kohota. Kardiovasku-
laarista painetta mittaavilla implantoivilla paineantureilla tarkastellaan esimerkiksi 
sydämen toimintaa sydänkammion tukilaitteen asennuksen jälkeen.  
 
Lopuksi tutkielma käsittelee biohajoavia implantoitavia paineantureita, jotka tule-
vat käyttöön tulevaisuudessa. Tällä hetkellä biohajoavat paineanturit ovat testat-
tavana laboratorioissa ja eläinkokeissa. Monet testien tuloksista ovat lupaavia. 
Biohajoavat implantoitavat paineanturit tiputtavat tulehdusriskiä, sillä ne eivät tar-
vitse toista leikkausta kuten ei-hajoavat paineanturit, jotka tarvitsevat poistoleik-
kauksen.  
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1. INTRODUCTION 
Pressure is one of the most common things to measure from the body. Different pressure 
measurements are important diagnostic information for doctors. Sometimes pressure is 
monitored for making sure that the pressure values stay within desired rates during or 
after the operation. Pressures are measured in numerous parts of the body, including car-
diovascular pressures like blood pressures and intracranial pressures inside the skull. The 
location where the pressure is measured affects the results. Sometimes it is necessary to 
measure the pressure in locations where the pressure sensor must be inside the body, in 
order to be able to measure the pressure with accuracy.  
Implantable pressure sensors are pressure sensors that are placed fully or partially inside 
the body for measurement. These pressure sensors allow doctors to measure the pressure 
directly where they want to. For example, with non-implantable pressure sensors, doctors 
can measure blood pressure, but if the doctors want to monitor the blood pressure exactly 
in the aorta or inside the heart chambers, they need to use implantable pressure sensors. 
However, the disadvantage of implantable pressure sensors is the difficulty of placing 
them. They always require surgeon to place them.  
This thesis is about different applications, possibilities and challenges of implantable 
pressure sensors. The focus is on the basic structure of implantable pressure sensors, and 
on two applications: intracranial pressure (ICP) and cardiovascular pressure (CVP). In 
both of these applications the implantable pressure monitoring is important because non-
implantable monitoring cannot achieve the accuracy or continuous monitoring of implant-
able pressure sensors. Continuous monitoring is especially important and often the reason 
to use implantable pressure sensors. For example, if the pressure values inside the brain 
start to increase, doctors need to know about it immediately in order to react fast enough. 
The end of this thesis contain a glace to the future as well. It is likely that most implantable 
pressure sensors in the future will be biodegradable, as well as other implants and im-
plantable devices. Implantable biodegradable pressure sensors are not yet in diagnostic 
use, but they are developing fast and are already showing promising results.  
The structure of this thesis is the following: chapter two is about the basic structure of 
implantable pressure sensors and challenges that apply basically to every sensor. Chapter 
three discusses intracranial and cardiovascular pressure measurements, and chapter four 
is about biodegradable pressure sensors and where the studies are going with them. 
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2. IMPLANTABLE PRESSURE SENSORS 
All implantable pressure sensor systems consist of at least a pressure-sensing element and 
a method of transmitting the data to an external unit [1]. Both of these elements can create 
challenges when designing an implantable pressure sensor. The sensing element must be 
accurate enough for potential long-term implants and transmitting unit has to get power 
from somewhere in order to keep sending the data forward. All this also has to be done 
while considering that the size of the sensor cannot grow too big for patients’ comfort and 
the sensor must also have good biocompatibility like any implantable device. To keep the 
size of the sensor small enough, micro-electro-mechanical systems (MEMS) and nano-
electro-mechanical systems (NEMS) are the most used techniques for manufacturing im-
plantable pressure sensors. [2] 
2.1 Basic structure of the implantable pressure sensor  
Implantable pressure sensors can be categorized into wireless and non-wireless sensors. 
Both sensor types include the sensing element and a monitor where the results of the 
measurement can be observed. The difference between wireless and non-wireless pres-
sure sensors is the method of transferring the data from inside the body to the monitor. 
With non-wireless sensors the sensing element is directly connected to the monitor with 
wires. The wires also transmit power to the sensor, as well as data from the sensor. Wire-
less sensors are not connected directly to the external monitor but have a transmitting unit 
in them which sends data wirelessly to the external monitor. For wireless sensors there 
are two possible power solutions. Firstly, that the system has its own power source, and 
secondly, that the system is remotely powered [2]. There are different sensing methods 
for implantable pressure sensors. The sensing systems are typically membrane-based 
MEMS capacitive sensors or piezoresistive sensors [3] but some of the sensors are also 
optical fiber pressure sensors [1]. The sensing systems are the same for wireless and non-
wireless sensors.  
2.1.1 Different sensing methods 
The basic sensing method for membrane-based capacitive sensor is simple. The mem-
brane of the sensing element has one of the electrodes of the capacitor, and when it is 
under pressure it deflects, changing the distance between electrode plates and changing 
the capacitance of the circuit [1], [3]. The same method is used widely on many types of 
pressure sensors. The simple basic structure of the circuit allows MEMS technology to 
make it in small enough scale for implantable sensor. The idea is presented in Figure 1. 
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Figure 1. Capacitive-based sensor’s idea. [1] 
The piezoresistive pressure sensors are practically always silicon based. The working 
principle is the Piezoresistive effect, which means a change in resistivity when the con-
ducting material gets strained. [4], [5] The design of the piezoresistive pressure sensor 
includes a silicon diaphragm that has piezoresistive elements mounted onto it. Most com-
monly, four  equal piezoresistors are placed in the membrane of the silicon diaphragm 
and connected to a Wheatstone bridge (WSB) [6]. A Wheatstone bridge is presented in 
Figure 2.  Any stress on the silicon diaphragm will change the resistivity of the circuit, 
which can be seen linearly in the output voltage. [4] When there is no pressure applied to 
the sensor, all of the piezoresistors have same resistance and therefore the output voltage 
is zero. [7]  
 
Figure 2. Wheatstone bridge circuit. [4] Vin and Vout are input and output voltages and 
R stands for piezoresistor. 
Some pressure sensors have an optical sensing unit. An optical sensing unit includes a 
light emitting unit, and two optically flat mirrors which are parallel to each other. The 
principle is shown in Figure 3. The light enters the chamber between the mirrors, and 
reflects multiple times before leaving the chamber. One the mirrors are on a highly sen-
sitive diaphragm and when the pressure is applied to the sensor, the distance between the 
mirrors changes, changing the intensity of optical output. [8]  
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Figure 3 The principle of optical sensing unit. [8] 
A sensor can have more than one sensing unit in it. Especially capacitive or piezoresistive 
sensors can have multiple sensing units in array formation, to get better sensitivity. The 
sensor still has only one sensing plate, but the pressure applied is measured with more 
than one capacitor or WSB. [9]  
2.1.2 Power solutions 
Receiving the data from an implanted wireless pressure sensor requires a wireless com-
munication system, which necessitates some sort of power. The power sources for im-
plantable pressure sensors can be divided into two different categories. In the first one the 
pressure sensor has its own power source. The second one is called telemetry, where the 
sensor itself does not include a power source of its own. Telemetry can also be divided 
into two categories which are called active and passive telemetry. [2] Wireless connection 
with a long-term pressure sensor is important for patient’s safety, if the implantable sensor 
has wires, the risk for infection grows dramatically. Non-wireless implantable pressure 
sensors are used in short-term use only. [1] 
In case where the pressure sensor itself includes a power source, the wireless transmission 
is only for data. The advantage of this is that the transmitted data can have a high band-
width, while the obvious disadvantage is that the batteries have a limited lifetime. Also, 
the size of the implantable pressure sensor grows if it has power source of its own. [2]   
In active telemetry the implantable pressure sensor does not have its own power source. 
However, it does have a transmitter and receiver for communication with an external de-
vice. The pressure sensor is powered remotely by the external device. [2] The powering 
can be done with inductive coupling, where an external coil is kept close to the implanted 
sensor, which includes a coil of its own. The external coil is powered with suitable fre-
quency and it gives power to the internal coil through induction and the coil works as a 
power receiving unit of the sensor circuit. [10] After obtaining power, the sensor can 
transmit the data forward.  
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Passive telemetry differs from active telemetry by sensor itself having absolutely zero 
active electronics, such as microcontrollers or an amplifier. It still has an LC-circuit as a 
transmitting unit which can communicate with an external coil. The resonant frequency 
shifts of the LC tanks can be converted into pressure changes. [1]  
When comparing these three power solutions with each other, it depends on the applica-
tion and placement of the pressure sensors which power solution is the best for the sensor. 
The battery powered sensors enable continuous data collection better than other two, and 
the range of wireless communication is up to 10 meters, whereas with telemetry the range 
is tens of centimeters. However, the limited lifetime and large size makes battery power 
unfit for long-term applications. Passive telemetry enables the smallest size and longest 
lifetime for the pressure sensor, but has the smallest data bandwidth and wireless range. 
The pressure sensor’s application and implant’s location are the determining factors when 
choosing which power solution will be used. [2]     
2.1.3 Transmitting unit 
Transmitting the data from a sensor to an external unit in a wireless pressure sensor has 
two main options, which are inductive link and radio frequency (RF) link. Inductive link 
needs the external device closer to the sensor than RF link. RF link can transit also more 
data with minimal errors. [11] However, an inductive link can be smaller in physical size 
and works with less power than RF link.  
The tissue around the antenna has huge impact on the impedance and the resonance fre-
quency of the antenna [12]. That is why the design of the antenna needs to be done while 
considering the application of the sensor. Parameters that needs to be considered when 
designing antenna for implantable pressure sensor are frequency bands, safety issues, po-
larization and power consumption. [11] 
2.2 Challenges with implantable pressure sensors  
Biocompatibility is always a challenge for implantable devices, especially for electrically 
active circuits. Interacting with warm and saline body fluids is an environment that can 
cause corruption on an electric circuit. It can also cause corrosion and highly negative 
foreign body reaction. [1] One of the solutions for this is biocompatibility coating [11]. 
However, a more common solution is micropacking or using micropackaging and coating 
together [13]. The reason for packing being more popular is that coating materials are so 
thin and can unbond, creating problems again with biocompatibility [14]. Even in a case 
where the device is fractured, it should not contain any toxic materials that might be re-
leased into the body [2].  
Polymers are the most used packaging materials. Silicone gels are used to cover the sens-
ing element for low viscosity so that the sensing element remains sensitive. For the rest 
6 
of the sensor, polymers like epoxy are used to cover them. Parylene-C is a popular coating 
material. [13] One of the factors for choosing packing materials is how easy it is to steri-
lize and if the sterilizing method works for the pressure sensor as well [14].  
One of the other challenges for implantable pressure sensors are to get is accurate data in 
long-term measurements. Calibration is a big part of getting accurate and true results. 
Some non-wireless pressure sensors can be calibrated even after placing them in the body, 
but most of the implantable pressure sensors needs to be calibrated beforehand. The sen-
sors’ accuracy also often gets lower after being implanted. Two main reasons for drifting 
are changes in the environment where the sensor is implanted (and calibrated), and me-
chanical fatigue that can occur from ageing. [2] 
Other big challenges for wireless implantable pressure sensors is are get accurate data 
safely to the doctors. Using radio frequency antenna includes a couple of issues. One of 
the issues that RF implants need to consider is the tissue absorption. It is the amount of 
electromagnetic energy that is reduced while the signal is coming through human tissue. 
[12] With higher frequency level the amount of energy absorbed by human body in-
creases, which can be harmful for the tissue. However, with low frequency levels the 
amount of data transferred decreases, which can effects on the accuracy of the data. The 
other issue is power consumption. The power consumption is an issue for the whole im-
plant, but normally the communication takes the most energy in implantable sensors. One 
reason to keep the power consumption as low as possible is that it generates heat that can 
be harmful for surrounding tissue. [2] Communicating with an inductive link has issues 
as well. The distance between sensor and external device needs to be minimum, which 
means that the sensor’s transmitting unit needs to be in the surface of the body. There is 
also higher possibility of Bit Rate Error (BRE) in inductive link communication compared 
to RF link. [11]  
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3. APPLICATIONS FOR IMPLANTABLE PRES-
SURE SENSORS 
Implantable pressure sensors have many applications. The most commonly measured 
pressures are intracranial pressure (ICP), cardiovascular pressure (CVP), intraocular pres-
sure (IOP) and bladder pressure. The reasons to use internal measuring for pressure in-
stead of external are that sometimes doctors cannot measure the desired pressure exter-
nally, and with internal measuring doctors often get more continuous and more accurate 
data. [1] The next section goes through the ICP and CVP sensors and couple different 
applications and methods of measuring them.  
3.1 Intracranial pressure measurements 
Intracranial pressure refers to the pressure inside the skull and brain tissue [15]. ICP mon-
itoring is important for patients who have a traumatic brain injury (TBI) [16]. TBIs can 
be caused by traffic accidents, sport injuries or any kind of strong hit to the head, which 
assaults a strong external force on the brain. With ICP monitoring the doctors are able to 
see if the pressure in the brain starts to increase. Increased ICP can cause intracranial 
hemorrhaging, neurological problems, coma, visual impairment, stroke or even death. 
[15] Placing the implantable ICP sensor requires neurosurgery, which is always a risk to 
the patient. However, often in case of TBI monitoring ICP is critical despite the risk of 
the surgery. [16]  
3.1.1 Measurement methods 
If possible, ICP is most often measured with implantable pressure sensors in cases of TBI. 
Some non-invasive techniques also exist, but they are less accurate [15]. Non-invasive 
ICP measurement is based on studies that show that the change of ICP is associated with 
changes of flow velocity and arterial blood pressure, which can both be recorded with 
non-invasive techniques [17]. Non-invasive methods have been studied from the 1970s 
in order to find a replacement for invasive methods [18]. As previously stated, the results 
of non-invasive ICP measurements are not as accurate and are often referred to as esti-
mated intracranial pressure [15]. However, placing the implantable pressure sensor re-
quires a neurosurgeon, which is not available in every hospital. In these cases the non-
invasive methods are used, and if the estimated intracranial pressure is high, the patient 
is most often transferred to another hospital with a neurosurgeon.  
ICP is measured in millimeters of mercury (mmHg) [15]. The linear (and accurate) range 
requirement of ICP sensor is from 0 mmHg to 70 mmHg [19]. Normal ICP values are 
between 7-15 mmHg for adult and over 20 mmHg is already life threating [15].  
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3.1.2 Implantable ICP sensors 
There are a couple of different ways of categorizing implantable ICP sensors. One way is 
that they can be divided to microtransducer devices and external ventricular drainage 
(EVD) -systems. EVD is different from other sensors, because it can be used also for 
drainage of cerebrospinal fluid (CSF). [20] ICP sensors are normally placed in either the 
brain tissues or the ventricles [17].  
With both, EVD and microtransducer devices, it is advantageous if the monitoring system 
does not contain ferromagnetic components which would prevent patients from magnetic 
resonance imaging (MRI) [20]. MRI is currently the most used diagnostic application for 
brain injuries. Brain tissue is very sensitive to increased heat and even 1 °C temperature 
increase can be very damaging. The MRI coils can induce large voltages to some ICP 
sensors which could cause unnecessary heat around the sensor’s transmitting unit. [21] 
This is one of the biggest reasons why most of the ICP sensors are not wireless or even if 
they are, the transmitting unit can be external. The reasons for using internal transmitting 
unit are that a physical connection with brain and external environment is huge risk factor 
for infections and limits the time of the monitoring. [22] However, in most cases, a short 
monitoring period is enough, and the measuring can be done with a system with a physical 
link to the external computer. With non-wireless system the maximum monitoring period 
is five to seven days, but often the monitoring time is shorter. 
 
 
Figure 4. Different areas of the brain where the ICP is measured. [23] 
Microtransducer ICP monitoring devices can be divided by their sensing method to fiber 
optic devices, strain gauge devices and pneumatic sensors. The microtransducer ICP 
monitoring devices are widely used to measure ICP from different intracranial locations, 
such as intraventricular and intraparenchymal, and in rare cases epidural, subdural and 
subarachonidal. [20] The locations are presented in Figure 4. Often the location where 
the pressure is wanted to be measured, is not on the surface of the brain. In that case the 
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sensing unit is placed on the desired location with sensor leads. Sensor leads are wires 
that are coated with isolating and biocompatible material, normally with medical silicone. 
If the sensor’s communication with a computer is wireless, the transmitting unit is placed 
outside the cranial bone, under the skin, so the communication distance with external 
device is minimal [22]. In Figure 5A is shown Raumedic’s Neurovent P-tel wireless ICP 
sensor and in Figure 5B is shown Raumedic’s wireless reading device of the ICP.  
  
Figure 5: A) Raumedic’s wireless ICP sensor. B) Wireless reading of the ICP. [24] 
EVD system’s catheter is traditionally placed into a ventricle through a coronal burr-hole. 
It measures the intraventricular pressure, and if the pressure rises too high, it drains CFS 
from the ventricle which lowers the ICP. EVD catheter is presented in Figure 6. As well 
as with the other sensors, EVD must be placed using neurosurgery. The surgery itself is 
considered a minor surgical procedure, but especially with younger patients placing the 
EVD can be difficult because of the small size of the ventricle. Ventricular size widens 
with age, so this problem is more common with young patients.  The risks with placing 
the EVD are minor, but there is a risk of postoperative hemorrhage and infection. That is 
why the routine CT scan is important after placing EVD. [20] To avoid infection, EVD 
catheter can also be impregnated with antibiotics [25]. However, even with impregnated 
catheters infections can occur [26]. 
 
Figure 6: Integra® Camino® Flex Ventricular Catheter. [27] 
EVD system is the most used intraventricular pressure sensor. Two main reasons make it 
so popular. The first one is, as already mentioned before, that it can drain CSF to lower 
the pressure in case the ventricular pressure is increasing too much. The second is that it 
can be calibrated anytime, which increases the accuracy and the reliability of the sensor. 
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[20] Normal sensitivity of the EVD ICP sensors are in the range of 2 µV/V/mmHg to 0.17 
mV/V/mmHg [7].  
At Tampere University of Technology Behfar et al. [28] studied a fully implantable pas-
sive sensor for continuous wireless subdural ICP monitoring. The sensor is capacitive and 
the size of it is 1.4x1.4x0.8 mm3 and it is made minimally invasive. The transmitting of 
the pressure values is done by inductive link with an external reader coil on-body. The 
focus of the study was the accuracy of the inductive link with reader coil. The changes in 
the reader coil’s input impedance’s magnitude and phase as well as the resonance fre-
quency were measured in 5 mmHg intervals between 0 and 70 mmHg. The results show 
that the most accurate and linear readout can be achieved with measuring the phase angle 
variations of the reader coil’s input impedance instead of magnitude of input impedance 
or the resonance frequency. [28] 
In another study Behfar et al. [29] researched an inductive passive pressure sensor for 
intraventricular and intraparenchymal ICP monitoring. The sensor includes a miniature 
pressure sensing unit, which is capacitive and placed either inside a ventricular or in the 
parenchymal for measurement. Besides the sensing unit, the sensor also includes a sub-
cutaneous spiral coil and an ultra-flexible and thin coaxial cable to connect the coil to the 
sensing unit. An external coil with a RF antenna is coupled with the internal coil to send 
the pressure values forward. The study shows that frequency shift of external coil is wider 
with intraventricular ICP measurements than intraparenchymal ICP measurements in the 
range of 10 to 70 mmHg, which means that intraparenchymal ICP monitoring would re-
quire a more sensitive sensor than intraventricular ICP monitoring. However, the accurate 
readout resolution in this study is 5 mmHg, while in ICP measurements the ideal resolu-
tion is 1 mmHg. As Behfar et al. writes: “Therefore, further study on this topic is neces-
sary to improve resolution, repeatability and sensitivity of the measurement.” [29] 
In table 1 is presented 4 different ICP sensors: Camino® Intracranial pressure monitoring 
catheter model 110-4L [30], Codman Microsensor ICP Transducer [31], Raumedic® 
ICP-TEMP-Monitoring-system [32] and Raumedic® Neurovent P-tel [33]. Camino’s 
sensor is the only one in the table that is fiber optic. It is also smallest in size. The sensing 
ranges of Raumedic’s two sensors are wide compared to other two. Raumedic® Neu-
rovent P-tel is the only wireless ICP monitor in this table, which can also be seen from 
the lifetime of the implant. Raumedic’s sensors have also low drifting during the lifetime 
of the sensor.  
 
 
 
 
11 
Table 1: Technical information of different ICP sensors 
Product Sensing 
method 
Size Range Zero drift Placement Lifetime 
Camino® Intracranial 
pressure monitoring 
catheter model 110-
4L 
Fiber optic 1.35mm 
diameter 
-10 to 
125 
mmHg 
less than ± 1 
mmHg per 
day 
Parenchymal or 
ventricular 
5 days 
Codman Microsensor 
ICP Transducer 
Piezoresis-
tive strain 
gauge 
n/a n/a less than 5.0 
per 7 days 
Parenchymal, 
subdural, or 
ventricular 
Surgeon 
discre-
tion 
Raumedic® ICP-
TEMP-Monitoring-
system 
Piezoresis-
tive strain 
gauge 
1.67mm 
diameter 
-50 to 
250 
mmHg 
Less than 
2mmHg dur-
ing the first 7 
days 
Parenchyma or 
ventricle 
7 days 
Raumedic® Neu-
rovent P-tel 
Piezoresis-
tive straun 
gauge 
1.67mm 
diameter 
-20 to 
400 
mmHg 
±2.0 mmHg 
per month  
Parenchyma 90 days 
 
3.2 Cardiovascular pressure measurement  
3.2.1 Reasons for cardiovascular pressure monitoring 
Heart diseases, like hypertension (high blood pressure), are one of the most common 
causes of death in industrial countries. To get the optimal treatment, it is important to 
have the possibility of continuous monitoring of arterial blood pressure over extended 
periods of time. [34] Non-invasive methods of measuring blood pressure are not contin-
uous or accurate enough. However, they are more commonly used, because they are much 
easier to use and they cause less discomfort to the patient. They also do not have the risks 
of infection that the operation of placing implantable sensor brings. [35] Non-wireless 
invasive catheter based devices are used, but they cannot offer long term monitoring, 
because of the increased risk of infections and thrombosis. Fully implanted wireless blood 
pressure system is one way of achieving continuous monitoring of cardiovascular pres-
sure (CVP). [34] 
Cardiovascular pressure is measured for different reasons and from different locations. In 
the Figure 7 is shown the anatomy of the heart [36]. From the figure can be found aorta, 
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atriums and pulmonary arteries, which all are examples of locations where doctors could 
want to monitor the blood pressure. Table 2 shows the estimated requirements for some 
different applications of blood measure monitoring [2].   
 
Figure 7 Heart anatomy. [36] 
 
Table 2: The estimated requirements for different blood pressure applications 
 
Aliments Measure location Typical values 
(mmHg) 
Required range 
(mmHg) 
Heart failure Pulmonary artery 8 to 30 0 to 100 
Coronary artery disease Downstream of stent or 
blockage 
60 to 150 20 to 250 
Abdominal aortic aneurysm Between graft and aneu-
rysm wall 
20 to 90 20 to 250 
Hypertension and auto-
nomic dyreflexia 
Artery 60 to 150 20 to 250 
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3.2.2 Different implantable cardiovascular pressure sensors 
Integrating medical stent with a wireless implantable cardiac sensor allows the placement 
of the sensor basically anywhere in the circulatory system [37]. Integrating the stent with 
application-specific integrated circuit (ASIC) allows the sensor to be active, which in-
creases the communication distance of the sensor. With an active stent sensor the com-
munication distance can be over 10 centimeters, which allows the external device to com-
municate with the sensor almost anywhere in circulatory system. [37] With the pressure 
sensor integrated to the stent it allows the doctors to see if the stent works.  
Pais et al. [38] introduce an implantable blood pressure monitoring cuff that goes around 
the artery. The device is currently only used for rats and other small laboratory animals, 
but in the future it could also be used for humans. The sensor is placed around the artery 
and provides continuous blood pressure measurements for days. It uses a piezoresistive 
sensor. Figure 8A shows the computer aided design of the sensor and in Figure 8B the 
device has been implanted into a rat. The results with this device were highly positive. It 
allows for the blood measurement of the rat without stressing the rat with, for example, 
an invasive catheter tip which can affect the results. Also in vitro testing the device fol-
lowed applied pressure accurately. [38] One of the goals for wireless implantable pressure 
sensors is that they would not cause any stress effect for the patient, which would affect 
the results of blood pressure monitoring. Some patients experience stress when visiting 
hospitals, which can be seen in results from a singular measurement with a non-implant-
able pressure sensor. Using a wireless implantable pressure sensor for continuous moni-
toring instead of a singular snapshot, which can be affected with stress or other possible 
peaks, is therefore much more accurate less affected by the environment. [1] 
  
Figure 8 A) The computer aided design of blood pressure cuff. B) Blood pressure cuff 
implanted to rat. [38]   
Fiala et al. [34] also presented a sensor that would be placed around the arteria. The sensor 
uses an optical sensing unit and active telemetry. The sensor acquires also other cardio-
vascular information than just intravascular pressure. It also measures electrocardiograph 
(ECG) and photoplethysmographic (PPG) and uses all these to calculate pulse transit time 
(PTT). The sensor is presented in Figure 9. The sensor have been tested in vivo with pigs. 
[34]  
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Figure 9 Optical sensor to measure intravascular pressure and pulse transit time. [34] 
The optical sensor which Fiala et al. presented allows the blood pressure measurement 
without applying external pressure to the artery, which could cause artery deform and 
affect the blood flow inside the vessel [34]. The sensor measures also ECG, PPG and PTT 
so the sensor could be used as a part in implantable drug delivery system or nerve stimu-
lation device in the future for chronic hypertension patients. The first test results for this 
device were positive and the PTT values were determined with invasive methods for the 
first time. According to Fiala et al., the results were promising for implantable blood 
pressure regulation systems with a drug pump or nerve simulator as a closed loop system. 
[34] 
One of the conditions in which the doctors would need the pressure monitoring inside the 
heart is after implantation of a continuous-flow left ventricular assist device (LVAD) [39]. 
The LVAD is a device for helping the failing heart to function. Monitoring the left atrial 
pressure (LAP) allows the doctors to see that the LVAD is functioning correctly. LVAD 
can be a long-term implant and therefore LAP monitoring should be long term as well. 
For long term LAP monitoring Hubbert et al. [39] introduced a wireless MEMS pressure 
sensor called the Titan. The sensor itself is passive MEMS pressure sensor with titan 
package. The external device for monitoring the device is connected to the Internet, which 
allows the patients to do the measurements at home and the doctors are still able to get 
the real time data of the measurement. The sensor has been clinically tested in patients 
with LVAD. The longest period of The Titan sensor being implanted is 180 days. [39] 
The first FDA approved fully wireless device for heart failure monitoring was Cardi-
oMEMS HF System from St. Jude Medical [1], [40]. It received FDA approval in 2014. 
The device measures pressure within the pulmonary artery. It is a passive sensor and the 
communication with external device is through LC tank’s resonant frequency. The pres-
sure sensing method of the device is capacitive. CardioMEMS HF system is presented in 
Figure 10. Size of the device is 3.4 x 2 x 15 mm3. [40] 
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Figure 10: CardioMEMS HF System from St. Jude’s Medical. The sensor size is being 
compared to one dime (US 10 cents coin). [40] 
The procedure of placing the CardioMEMS™ HF system to the pulmonary artery is rel-
atively simple. With a minimally invasive operation, a catheter is placed in pulmonary 
artery advantage along with the guide wire to assure that the implant will go into target 
vein. The delivery tool for the CardioMEMS™ follows the wire. Once the delivery tool 
is in the correct place, the wires that can be seen in Figure 10 are released from the deliv-
ering tool, anchoring the pressure sensor to its location. [41] 
After placing the CardioMEMS™ HF system into the pulmonary artery, the readings of 
the pressure values can be done at home. The electronic unit that completes the measure-
ments will automatically send the readings to the secured website, where the patient’s 
doctor will have access. The readings are meant to be done daily for continuous monitor-
ing. [42] The continuous data from the CardioMEMS™ HF system, which monitors the 
pulmonary artery pressure and heart rate, allows doctors to diagnose possible heart failure 
and act on it by making changes to the treatments even before the patient notices any 
symptoms. The CardioMEMS™ HF system is placed in patients with either a history of 
heart failure or patients that are considered to have increased risk for heart failure, due 
some other heart disease. [43]   
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4. BIODEGRADABLE PRESSURE SENSORS 
Advantages of implantable biodegradable pressure sensors compared to regular pressure 
sensors are mostly the same as the advantages with any biodegradable implants. The most 
obvious one is that there is no need for the second surgery, which lowers the risk for 
infection and other issues that are always present with operations. Secondly biodegrada-
ble materials have often good biocompatibility and the sensors themselves are less likely 
to cause negative foreign body reaction. Biodegradable implants are also environmental 
friendly, because they do not create any electronic waste [44]. It is easy to see that in the 
future biodegradable pressure sensors will become more common. Biodegradable pres-
sure sensors are not yet in diagnostic use, but there are a lot of different sensors that are 
being tested in vitro and in vivo for animals.  
4.1 Materials and structure  
The basic idea of biodegradable pressure sensor is that after it has fulfilled its purpose as 
diagnostic device, it will safely be absorbed by the body [44]. The dissolve time depends 
on the materials. Polymers such as polylactic-co-glycolic acid (PLGA), polyvinyl alcohol 
(PVA), polylactic acid (PLA) [45] and polycaprolactone (PCL) [46] are for example used. 
Different polymers have different degradation rates, and by using co-polymers or blends 
of these materials can be achieved the wanted degradation time. The conducting materials 
needs to be biodegradable as well, or at least dissolve into so small molecules, that the 
body is able to get rid of them. Zinc, iron and magnesium and their alloys are for example 
used. In the sensing unit silicon and silicon oxide are common materials [19]. The size of 
the sensor does not necessary effect on the degradation time. The same stages and per-
centage weight losses can be found from two different sized pressure sensors made from 
same material [45]. The functional lifetime of the pressure sensor can be just a small 
fraction of the degradation lifetime. For example, PLGA/PVA -based sensor has func-
tional lifetime of 24 hours and degradation lifetime of 25 days. [45] 
The basic structure of the biodegradable pressure sensor remains the same as regular im-
plantable pressure sensor. There is still sensing unit and transmitting unit. The sensing 
unit is most often piezoresistive or capacitive as in non-degradable sensors. Radio fre-
quency powered electronics are used in biodegradable pressure sensors as well. Majority 
of biodegradable pressure sensors use passive telemetry to communicate. However there 
are research about bio-battery systems that could be used in the future to create active and 
fully biodegradable pressure sensors as well. [44]  
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4.2 Comparing biodegradable to non-degradable implantable 
pressure sensors 
As already said before, the advantages of biodegradable pressure sensors to non-degrada-
ble ones are the same as any biodegradable implant. But there are some disadvantages as 
well. Calibration is often harder for biodegradable sensor and the functional lifetime var-
ies always a little bit with every individual case. It can be hard to know when the accurate 
functional lifetime is over.  
The sensitivity results of the biodegradable cardiovascular sensor presented by Boutry et 
al. [47] are really similar to non-degradable pressure sensor with similar design. The sens-
ing unit of the sensor is capacitive with 4 x 5 array formation. The sensing array is shown 
in Figure 11. [47] The array formation increases the sensitivity but can also cause higher 
error with multiple capacitors. However, often in cardiovascular monitoring the biggest 
interest is in the shape of the pulse wave, not in the absolute pressure value.    
 
Figure 11 Capacitive sensing array [47] 
Boutry et al. [48] introduced also an entirely biodegradable sensor that can measure both 
pressure and strain. This sensor is designed to monitor the progress of tendon repair after 
surgery. The pressure sensing unit is capacitive and uses the same array formation that is 
presented in Figure 11. [48] Using the biodegradable sensors to monitor the healing after 
surgery makes more sense than using non-degradable sensor, since non-degradable sensor 
would need another surgery to remove the sensor.  
One of the applications already presented in this thesis for cardiovascular pressure mon-
itoring was integrating medical stent with MEMS pressure sensor. There are also stents 
that are made from biodegradable materials, so it is logical to have biodegradable sensor 
on those as well. One of the biggest problems with biodegradable stent sensor is that while 
they are passive, the communication distance with external device cannot be too long. 
Finding the suitable operating frequency is also a challenge. High frequencies can deliver 
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high energy but also increases the amount of energy absorbed by human body and with 
low frequencies the sensitivity of the sensor gets weaker. [49]  
There are already many biodegradable pressure sensors under studies that show promis-
ing results. They have good sensitivity and multiple applications where they can be used. 
Monitoring the healing of surgery is a good example of application that benefits from the 
biodegradability of the sensor. There are still issues with biodegradable sensors, but the 
research is ongoing and have taken massive steps during the last five years. Comparing 
to the non-degradable sensors, the biodegradable sensors have many good qualities, but 
non-degradable sensors have longer history and the doctors are used to them. 
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5. CONCLUSIONS  
This thesis has discussed implantable pressure sensors, which are a diagnostic tool for 
doctors to measure pressure inside the body. Compared to non-implantable pressure sen-
sors, the advantages of implantable sensors are that pressure can be measured more di-
rectly from a desired location and the monitoring is continuous and more accurate. Dis-
advantages include the difficult placing of the sensor, which always requires a surgical 
operation. Operations always include risks for infections.  
When designing implantable pressure sensors there are multiple things to take in to ac-
count, such as choosing the sensing method, the method of data transfer, and power solu-
tions. For sensing methods, the most commonly used are piezoresistive and capasitive 
sensing elements, but other techniques are also used. For data transfer and power solu-
tions, it is important to first choose if the implantable pressure sensor is going to be wire-
less or not. This is an important decision, because it makes significant difference in the 
monitoring time of the sensor. All these decisions are made based on the desired applica-
tion of the implantable pressure sensor.  
For long-term wireless pressure sensors, the data transferring, long-term accuracy and 
receiving power are challenges that need to be adressed. The most used techniques for 
data transferring are using radiofrequencies or an inductive link. Choosing the data trans-
ferring method is highly related to power solutions as well as the accuracy of the sensor. 
The size of the sensor cannot grow too much for the comfort of the patient and the safety 
of the device needs to be number one priority.  
Intracranial and cardiovascular pressures are two instances in which implantable pressure 
sensors are used. Intracranial pressure is often monitored after traumatic brain injury, be-
cause it can increase slowly after a major hit in the head. Increased intracranial pressure 
can have even lethal consequences, so if the intracranial pressure starts to increase, doc-
tors need to be able to react quickly. This is why an external ventricular drainage -system 
is the most popular system for monitoring intracranial pressure, because it can drain the 
cerebrospinal fluid from ventricles in case the pressure starts to increase.  
Cardiovascular pressure is measured from many different locations in the circulatory sys-
tem. Blood pressure values are key element in diagnosing different heart diseases. With 
implantable pressure sensors the blood pressure can be monitored from different veins or 
even inside the heart chambers. Besides using the implantable pressure sensors for diag-
nostic purposes, they can be used for monitoring that the medication or heart assisting 
devices are working properly.  
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Biodegradable pressure sensors are the future of implantable pressure sensors. There are 
many promising models which are now being tested in animals, and in a couple of years 
they will most likely be undergoing diagnostic tests. The main advantage of biodegrada-
ble pressure sensors is that there is no need for removing the sensor, so there is no need 
for a second surgery that non-degradable pressure sensors require. This lowers the risks 
for infection and other possible risk factors that every surgical operation has.   
This thesis has explored different kinds of implantable pressure sensors for different ap-
plications. The importance of continuous pressure monitoring for health of many different 
types of patients keeps the developing of implantable sensors going in the future as well. 
There are still only few fully wireless long-term monitoring devices available for doctors. 
When the patients are able to measure the values at home and send them to the doctors 
for analysis, it increases the value of the sensor for the patients as well as for the doctors. 
With the biodegradable pressure sensors the applications will increase as well, which will 
increase the use of wireless implantable pressure sensors in the future.  
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